HomeAI · summaries
Storia in 14 fonti
UPDATE: Peptides favored on 1st day of closely watched FDA compounding adcomm
An FDA advisory committee has recommended that three peptide drugs that were previously restricted because of potential safety concerns be restored to the 503A Bulk Drug Substances list, which woul | An FDA advisory committee has recommended that three peptide drugs that were previously restricted because of potential safety concerns be restored to the 503A Bulk Drug Substances list, which would remove the limits on how they are produced by compounders. It marks the first three of seven peptide drugs the FDA's Pharmacy Compounding Advisory Committee is addressing on Thursday and Friday.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
FDA’s Review Of Peptides Signals A Growing Public Health Challenge
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.
- ·
FDA Set To Review Safety And Access To Peptides: What You Need To Know
An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding pharmacies and the gray market.
